GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Incyte Corporation
Incyte Corporation
Bellicum Pharmaceuticals
Hamad Medical Corporation
Cellphire Therapeutics, Inc.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Terumo BCTbio
Janssen Korea, Ltd., Korea
Alaunos Therapeutics
Healios K.K.
Wyeth is now a wholly owned subsidiary of Pfizer
CASI Pharmaceuticals, Inc.